AAAAAA

   
Results: 1-8 |
Results: 8
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL)
Authors: KOBBE G BAUSER U RIETH C HUNERLITURKOGLU A SOHNGEN D AIVADO M AUL C HEYLL A
Citation: G. Kobbe et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) MEDIATED MOBILIZATION OF LEUKEMIC-CELLS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA EXPRESSING MYELOID ANTIGENS (MY+PH+ALL), American journal of hematology, 58(4), 1998, pp. 330-333
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL GRAFTS FROM 2 NORMAL DONORS OVER THE AGE OF 70 YEARS
Authors: KOBBE G SOEHNGEN D SCHNEIDER P RIETH C BAUSER U FISCHER J WERNET P AUL C HEYLL A
Citation: G. Kobbe et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL GRAFTS FROM 2 NORMAL DONORS OVER THE AGE OF 70 YEARS, Bone marrow transplantation, 21, 1998, pp. 5-5
HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA
Authors: HUNERLITURKOGLU A KOBBE G SOHNGEN D BAUSER U SCHNEIDER P THIELE KP MINNING H SUDHOFF T MECKENSTOCK G STRUPP C NIEDERSTEHOLLENBERG A AUL C HEYLL A
Citation: A. Hunerliturkoglu et al., HIGH-DOSE IDARUBICIN ADDED TO CVB AS AN INTENSIFIED HIGH-DOSE-CHEMOTHERAPY PROTOCOL FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 589-589
HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA
Authors: SCHNEIDER P SOHNGEN D KOBBE G BAUSER U HUNERLITURKOGLU A HEYLL A AUL C
Citation: P. Schneider et al., HIGH-DOSE IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE FOR TREATMENT OFMULTIPLE-MYELOMA, Bone marrow transplantation, 21, 1998, pp. 707-707
IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS
Authors: HEYLL A SOHNGEN D KOBBE G SCHNEIDER P BAUSER U THIELE KP WEHMEIER A SUDHOFF T QUENZEL EM RIETH C WERNET P FISCHER J FRICK M AUL C
Citation: A. Heyll et al., IDARUBICIN, MELPHALAN AND CYCLOPHOSPHAMIDE - AN INTENSIFIED HIGH-DOSEREGIMEN FOR THE TREATMENT OF MYELOMA PATIENTS, Leukemia, 11, 1997, pp. 32-34
INCREASES OF SICAM-1 DURING NEUTROPENIC PNEUMONIA IN LEUKEMIC PATIENTS
Authors: SUDHOFF T WEHMEIER A ARNING M BAUSER U SCHLOMER P AUL C SCHNEIDER W
Citation: T. Sudhoff et al., INCREASES OF SICAM-1 DURING NEUTROPENIC PNEUMONIA IN LEUKEMIC PATIENTS, Leukemia, 11(3), 1997, pp. 346-351
DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR
Authors: SOHNGEN D BAUSER U BOOGEN C AUL C FRIELING T GERMING U SCHNEIDER P KOBBE G HEYLL A
Citation: D. Sohngen et al., DOUBLE TREATMENT OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION WITH RECOMBINANTTISSUE-PLASMINOGEN ACTIVATOR, Thrombosis and haemostasis, 78(4), 1997, pp. 1299-1300
LEVELS OF CIRCULATING ENDOTHELIAL ADHESION MOLECULES (SE-SELECTIN ANDSVCAM-1) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA
Authors: SUDHOFF T WEHMEIER A KLICHE KO AUL C SCHLOMER P BAUSER U SCHNEIDER W
Citation: T. Sudhoff et al., LEVELS OF CIRCULATING ENDOTHELIAL ADHESION MOLECULES (SE-SELECTIN ANDSVCAM-1) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA, Leukemia, 10(4), 1996, pp. 682-686
Risultati: 1-8 |